Welcome to our dedicated page for Regencell Bioscience Holdings SEC filings (Ticker: RGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder (“adhd”), autism spectrum disorder (“asd”) in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
FAQ
What is the current stock price of Regencell Bioscience Holdings (RGC)?
The current stock price of Regencell Bioscience Holdings (RGC) is $12.8 as of August 22, 2025.
What is the market cap of Regencell Bioscience Holdings (RGC)?
The market cap of Regencell Bioscience Holdings (RGC) is approximately 6.1B.
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
RGC Rankings
RGC Stock Data
6.10B
19.01M
96.16%
0.14%
0.46%
Drug Manufacturers - Specialty & Generic
Healthcare
Hong Kong
Causeway Bay